Article
Pharmacological disruption of the MID1/α4 interaction reduces mutant Huntingtin levels in primary neuronal cultures.
Neuroscience letters - 23 Apr 2018
Monteiro Olivia, Chen Changwei, Bingham Ryan, Argyrou Argyrides, Buxton Rachel, Pancevac Jönsson Christina, Jones Emma, Bridges Angela, Gatfield Kelly, Krauß Sybille, Lambert Jeremy, Langston Rosamund, Schweiger Susann, Uings Iain
Abstract excerpt
Expression of mutant Huntingtin (HTT) protein is central to the pathophysiology of Huntington's Disease (HD). The E3 ubiquitin ligase MID1 appears to have a key role in facilitating translation of the mutant HTT mRNA suggesting that interference with the function of this complex could be an attractive therapeutic approach. Here we describe a peptide that is able to disrupt the interaction between MID1 and the α4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
